ArticleDiabetology international2022

Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.

Moeko Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.